Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 103, Issue 4, Pages 1686-1695
Publisher
The Endocrine Society
Online
2018-02-15
DOI
10.1210/jc.2017-02591
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
- (2017) Judith E K Henning et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma—A New Look at an Old Drug
- (2017) Diane L. Reidy‐Lagunes et al. ONCOLOGIST
- Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma
- (2016) Yuhree Kim et al. JAMA Surgery
- Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide
- (2016) Matthias Kroiss et al. Hormones & Cancer
- Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells
- (2015) Silviu Sbiera et al. ENDOCRINOLOGY
- Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
- (2015) Felix Beuschlein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- (2015) Martin Fassnacht et al. LANCET ONCOLOGY
- Adrenocortical Carcinoma
- (2014) Tobias Else et al. ENDOCRINE REVIEWS
- The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
- (2014) Ciara O'Sullivan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
- (2014) Antonio M. Lerario et al. Hormones & Cancer
- Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center
- (2013) Montserrat Ayala-Ramirez et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer
- (2013) Alfredo Berruti et al. EUROPEAN UROLOGY
- Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma
- (2013) T. M. Kerkhofs et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) A. Berruti et al. ANNALS OF ONCOLOGY
- The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma
- (2012) Ilknur Erdogan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination Chemotherapy in Advanced Adrenocortical Carcinoma
- (2012) Martin Fassnacht et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
- (2011) Ilse G. Hermsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma
- (2008) Martin Fassnacht et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now